Fang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fang Wang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Xiao-Liang Feng
Department of Epidemiology and Biostatistics School of Public Health Anhui Medical University Hefei China
6 shared publicationsYan-Feng Zou
Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China
5 shared publicationsFa-Ming Pan
Department of Epidemiology and Biostatistics School of Public Health Anhui Medical University Hefei China
2 shared publicationsF. M. Pan
Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China
1 shared publicationFen Huang
Department of Epidemiology and Biostatistics School of Public Health Anhui Medical University Hefei China
1 shared publicationH. Su
Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China
1 shared publication
Latest Publications
- 1 May 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47 (7) , 1072-1079
Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjects
- 1 May 2011
- Published by Elsevier in European Journal of Cancer
- Vol. 47 (7) , 1072-1079
Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjects
- 5 April 2011
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 128 (3) , 913-915
The association between IGF1 CA repeat polymorphisms and breast cancer risk: appraisal of a recent meta-analysis
- 5 April 2011
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 128 (3) , 913-915
The association between IGF1 CA repeat polymorphisms and breast cancer risk: appraisal of a recent meta-analysis
- 1 March 2011
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (3) , 781-782
TP53 Arg72Pro Polymorphism May Have Little Involvement in the Pathogenesis of Skin Cancer in Caucasians
- 1 March 2011
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (3) , 781-782
TP53 Arg72Pro Polymorphism May Have Little Involvement in the Pathogenesis of Skin Cancer in Caucasians
- 15 February 2011
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 128 (1) , 289-290
The association between two polymorphisms in the TYMS gene and breast cancer risk: appraisal of a recent meta-analysis
- 15 February 2011
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 128 (1) , 289-290
The association between two polymorphisms in the TYMS gene and breast cancer risk: appraisal of a recent meta-analysis
- 15 January 2011
- Published by Springer Nature in Rheumatology International
- Vol. 32 (1) , 283
“Heterozygous versus Homozygous” should be applied for complex diseases
- 15 January 2011
- Published by Springer Nature in Rheumatology International
- Vol. 32 (1) , 283
“Heterozygous versus Homozygous” should be applied for complex diseases
- 24 September 2010
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 125 (1) , 291-293
Lack of association between two SNPs (rs1800896 and rs1800872) in IL-10 gene promoter and breast cancer in Caucasians
- 24 September 2010
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 125 (1) , 291-293
Lack of association between two SNPs (rs1800896 and rs1800872) in IL-10 gene promoter and breast cancer in Caucasians
- 6 September 2010
- Published by Wiley in Tissue Antigens
- Vol. 77 (1) , 9-17
Association of NFKB1 ‐94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta‐analysis
The aim of our study is to assess the association of NFKB1 ‐94ins/delATTG promoter polymorphism with autoimmune and inflammatory diseases using a meta‐analysis. We surveyed the studies on the association of NFKB1 ‐94ins/delATTG promoter polymorphism with autoimmune and inflammatory diseases. Meta‐analysis was performed for genotypes DD vs WW, WD vs WW, DD vs WW + WD, WD + DD vs WW, and D allele vs W allele in a fixed/random effect model. Seventeen studies (7312 cases and 6193 controls) were identified. When all groups were pooled, we found no association between NFKB1 ‐94ins/delATTG promoter polymorphism and autoimmune and inflammatory diseases. In ethnic subgroup analyses, we found no association between NFKB1 ‐94ins/delATTG promoter polymorphism and autoimmune and inflammatory diseases in the Caucasian population. However, an association of NFKB1 ‐94ins/delATTG promoter polymorphism with autoimmune and inflammatory diseases was found in the Asian population [D vs W: odds ratio (OR) = 0.87, 95% confidence interval (CI) = 0.77–0.99, P = 0.03; WD + DD vs WW: OR = 0.79, 95% CI = 0.65–0.95, P = 0.01; DD vs WW + WD: OR = 0.92, 95% CI = 0.73–1.16, P = 0.11; DD vs WW: OR = 0.80, 95% CI = 0.62–1.03, P = 0.09; WD vs WW: OR = 0.78, 95% CI = 0.65–0.95, P = 0.01]. In disease subgroup analyses, we found no association between NFKB1 ‐94ins/delATTG promoter polymorphism and inflammatory bowel disease, ankylosing spondylitis and Graves' disease. This meta‐analysis suggests a possible association between NFKB1 ‐94ins/delATTG promoter polymorphism and certain autoimmune and inflammatory diseases in the Asian population, but not in the Caucasian population. This finding demands further investigation.
- 6 September 2010
- Published by Wiley in Tissue Antigens
- Vol. 77 (1) , 9-17
Association of NFKB1 ‐94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta‐analysis
The aim of our study is to assess the association of NFKB1 ‐94ins/delATTG promoter polymorphism with autoimmune and inflammatory diseases using a meta‐analysis. We surveyed the studies on the association of NFKB1 ‐94ins/delATTG promoter polymorphism with autoimmune and inflammatory diseases. Meta‐analysis was performed for genotypes DD vs WW, WD vs WW, DD vs WW + WD, WD + DD vs WW, and D allele vs W allele in a fixed/random effect model. Seventeen studies (7312 cases and 6193 controls) were identified. When all groups were pooled, we found no association between NFKB1 ‐94ins/delATTG promoter polymorphism and autoimmune and inflammatory diseases. In ethnic subgroup analyses, we found no association between NFKB1 ‐94ins/delATTG promoter polymorphism and autoimmune and inflammatory diseases in the Caucasian population. However, an association of NFKB1 ‐94ins/delATTG promoter polymorphism with autoimmune and inflammatory diseases was found in the Asian population [D vs W: odds ratio (OR) = 0.87, 95% confidence interval (CI) = 0.77–0.99, P = 0.03; WD + DD vs WW: OR = 0.79, 95% CI = 0.65–0.95, P = 0.01; DD vs WW + WD: OR = 0.92, 95% CI = 0.73–1.16, P = 0.11; DD vs WW: OR = 0.80, 95% CI = 0.62–1.03, P = 0.09; WD vs WW: OR = 0.78, 95% CI = 0.65–0.95, P = 0.01]. In disease subgroup analyses, we found no association between NFKB1 ‐94ins/delATTG promoter polymorphism and inflammatory bowel disease, ankylosing spondylitis and Graves' disease. This meta‐analysis suggests a possible association between NFKB1 ‐94ins/delATTG promoter polymorphism and certain autoimmune and inflammatory diseases in the Asian population, but not in the Caucasian population. This finding demands further investigation.